Molecular test Genotype®MTBDRplus, an alternative to rapid detection of multidrug resistance tuberculosis;Prueba molecular Genotype®MTBDRplus, una alternativa para la detección rápida de tuberculosis multidrogorresistente

Revista Peruana de Medicina Experimental y Salud Publica

Volumn 29, Issue 1, 2012, Pages 92-98

  Asencios, Luis ^a   Galarza, Marco ^a   Quispe, Neyda ^a   Vásquez, Lucy ^a   Leo, Elena ^a   Valencia, Eddy ^a   Ramírez, Juan ^a   Acurio, Margoth ^a   Salazar, Rosario ^a   Mendoza Ticona, Alberto ^a   Cáceres, Omar ^a  

^a INSTITUTO NACIONAL DE SALUD   (Peru)

Author keywords

Isoniazid; Molecular Diagnostic Techniques; Multidrug Resistant; Mutation; Peru; Rifampin; Tuberculosis; Validity of Tests

Indexed keywords

ISONIAZID; RIFAMPICIN;

AGAR PLATE PROPORTION; ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENOTYPE; HUMAN; LABORATORY TEST; MOLECULAR DIAGNOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATIONAL ANALYSIS; NONHUMAN; PERFORMANCE MEASUREMENT SYSTEM; REFERENCE VALUE; SENSITIVITY ANALYSIS; SPUTUM ANALYSIS;

EID: 84859992633     PISSN: 17264634     EISSN: 17264642     Source Type: Journal    
DOI: 10.1590/S1726-46342012000100014     Document Type: Article

References (16)

1. World Health Organization. Global Tuberculosis Control 2010: Annex 2 [Internet]. Ginebra: WHO; 2010 [citado el 11 de noviembre de 2011]. Disponible en: http://www.who.int/tb/publications/global_report/2010/gtbr10_a2.pdf
2. Comité de Tuberculosis Extremadamente Resistente. Análisis de la situación actual y propuesta de lineamientos técnicos para el control y prevención de la tuberculosis resistente en el Perú, 2008. Lima: TB XDR; 2008.
3. Telenti A, Honoré N, Bernasconi C, March J, Ortega A, Heym B, Takiff HE, Cole ST. Genotyping assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol. 1997;35(3):719-723.
4. Agapito J, Neyra V, Castro J, Accinelli R, Rodríguez I, Espinoza JR. Caracterización de las mutaciones en el gen rpoβ Asociadas a la resistencia a rifampicina en pacientes con tuberculosis pulmonar. Rev Peru Med. Exp Salud Publica. 2002;19(3):117-123.
5. Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol. 2007;45(8):2635-2640.
6. ® MTBDRplus; [aprox. 2 pantallas]. Disponible en: http://www.hain-lifescience.de/en/products/microbiology/mycobacteria/genotype-mtbdrplus.html
7. Kent PT, Kubica GP (ed). Public health mycobacteriology. A guide for the level III laboratory. Atlanta, GA: U.S. Department of Health, Education, and Welfare, Centers for Disease Control and Prevention; 1995.
8. World Health Organization [Internet]. Geneva: WHO; c2012 [citada el 25 abril del 2011]. Laboratory services in TB control (Publication no. WHO/tb/98.258.). Disponible en: http://www.who.int/tb/publications/who_tb_98_258/en/
9. Lacoma A, Garcia-Sierra N, Prat C, Ruiz-Manzano J, Haba L, Rosés S, et al. GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol. 2008;46(11):3660-3667.
10. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med. 2008 Apr 1;177(7):787-792.
11. Huang WL, Chi TL, Wu MH, Jou R. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2011;49(7):2502-2508.
12. Caviedes L, Lee TS, Gilman RH, Sheen P, Spellman E, Lee EH, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol. 2000;38(3):1203-1208.
13. Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med. 2006;355(15):1539-1550.
14. Rossau R, Traore H, De Beenhouwer H, Mijs W, Jannes G, De Rijk P, et al. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother. 1997;41(10):2093-2098.
15. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363(11):1005-1015.
16. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010;48(1):229-237.